Scientific Advice (SA) is one of the important interactions a developer can have with a regulatory agency (national or European level). It can facilitate the development and availability of high-quality, effective and acceptably safe medicines, for the benefit of patients. In this session, we answer the questions on SA such as:
- When the developer can request a SA?
- What are the different SA procedures?
- Why request a SA?
- What’s the difference between a National Scientific Advice vs an EMA scientific Advice?
Access the full webinar replay now
Fill in the form to download the content
Featured Speakers
Private: Lise Merlay Barbin PhD, Eng.
Senior Director, Regulatory Science
As a Director, Regulatory Science, Lise manages projects from early stages of development to late clinical development phases and up…
View profile
Peri Aghadiuno, MBBS, MRCOG
Senior Medical Director
As a Senior Medical Director at VCLS, Peri is responsible for providing input to, and critical review of, the clinical sections of a…
View profile
All our resources 
